SignatureFD’s Vera Therapeutics VERA Stock Holding History

SignatureFD’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-76	Closed	-$1.83K	–	3438
2025 Q1	$1.83K	Buy	+76	New	+$2.44K	﹤0.01%	2901

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

SignatureFD's VERA Position: Q2 2025 in Review

SignatureFD sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 76 shares — an estimated $1.83K sold.

SignatureFD first reported a position in VERA in Q1 2025 and held it in 1 quarter. The position peaked at $1.83K in Q1 2025. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

SignatureFD reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
SignatureFD sold 76 Vera Therapeutics shares in Q2 2025, an estimated $1.83K.
SignatureFD first reported a position in Vera Therapeutics in Q1 2025 and held it in 1 quarter.
SignatureFD's Vera Therapeutics position peaked at $1.83K in Q1 2025.
172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.